Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04480502
PHASE2

ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma

Sponsor: Tracon Pharmaceuticals Inc.

View on ClinicalTrials.gov

Summary

This is a multicenter open-label, randomized, non-comparative, parallel cohort pivotal study of treatment with envafolimab (cohort A and C) or envafolimab combined with ipilimumab (cohort B and D) in patients with locally advanced, unresectable or metastatic undifferentiated pleomorphic sarcoma (UPS)/myxofibrosarcoma (MFS) who have progressed on one or two lines of chemotherapy.

Official title: ENVASARC: A Pivotal Trial Of Envafolimab, And Envafolimab In Combination With Ipilimumab, In Patients With Advanced Or Metastatic Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma Who Have Progressed On Prior Chemotherapy

Key Details

Gender

All

Age Range

12 Years - Any

Study Type

INTERVENTIONAL

Enrollment

207

Start Date

2020-12-09

Completion Date

2024-10

Last Updated

2024-05-17

Healthy Volunteers

No

Interventions

BIOLOGICAL

Envafolimab

PD-L1 single domain antibody for subcutaneous injection.

DRUG

Ipilimumab

CTLA-4 monoclonal antibody

Locations (30)

University of Arizona

Tucson, Arizona, United States

University of California, Los Angeles

Los Angeles, California, United States

Sarcoma Oncology Research Center

Santa Monica, California, United States

Stanford University

Stanford, California, United States

University of Colorado

Aurora, Colorado, United States

Mayo Clinic, Jacksonville

Jacksonville, Florida, United States

University of Miami

Miami, Florida, United States

H. Lee Moffitt Cancer Center

Tampa, Florida, United States

Northwestern University

Evanston, Illinois, United States

Johns Hopkins University

Baltimore, Maryland, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

Dana Farber Cancer Institute

Boston, Massachusetts, United States

University of Michigan

Ann Arbor, Michigan, United States

Mayo Clinic Rochester

Rochester, Minnesota, United States

Washington University in St. Louis

St Louis, Missouri, United States

Columbia University

New York, New York, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Duke University

Durham, North Carolina, United States

University Hospitals

Cleveland, Ohio, United States

Cleveland Clinic

Cleveland, Ohio, United States

Ohio State University

Columbus, Ohio, United States

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Thomas Jefferson University (Sidney Kimmel Cancer Center)

Philadelphia, Pennsylvania, United States

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

Vanderbilt University

Nashville, Tennessee, United States

Huntsman Cancer Institute

Salt Lake City, Utah, United States

Virginia Commonwealth University

Richmond, Virginia, United States

Seattle Cancer Care Alliance

Seattle, Washington, United States

Medical College of Wisconsin

Wauwatosa, Wisconsin, United States

Royal Marsden

London, United Kingdom